A Drug-Environment Interaction Between PM2.5 Concentration and Corticosteroid Use on Cardiovascular and Thromboembolic Events in Older Adults - Summary - MDSpire
To evaluate the synergistic effects of PM2.5 exposure and corticosteroid administration on cardiovascular and thromboembolic events in elderly individuals with chronic conditions.
Approach:
Study Population: Data from the Taiwan National Health Insurance Database (NHID) covering 2009-2019 was used, focusing on patients with chronic conditions at high risk for cardiovascular and thromboembolic events.
PM2.5 Exposure Assessment: Seasonal average PM2.5 concentrations were linked to the NHID based on postcode, utilizing data from 85 monitoring stations across Taiwan.
Corticosteroid Exposure Assessment: Systemic corticosteroid exposure was identified through prescription dispensing claims using ATC codes, focusing on various corticosteroids used for chronic respiratory conditions.
Key Findings:
PM2.5 exposure is associated with increased risk of cardiovascular and thromboembolic events.
Corticosteroids are known to elevate the risk of cardiovascular incidents and thromboembolic events.
The interaction between PM2.5 and corticosteroid exposure may have synergistic effects on heart failure and myocardial infarction.
Interpretation:
Limitations:
Limited to data from Taiwan, which may not be generalizable to other regions.
Potential confounding factors not accounted for in the analysis.
by Shu-Ping Huang, Chien-Chou Su, Rachel Nethery, Kevin Josey, Benjamin Bates, David Robinson, Poonam Gandhi, Melanie Rua, Ashwaghosha Parthasarathi, Soko Setoguchi, Yea-huei Kao Yang
National survey findings suggest many US adults report making health decisions based on social media despite widespread concerns about the accuracy of health information shared to the platforms.
